These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32738435)

  • 41. Generation and Characterization of a Bispecific Antibody Targeting Both PD-1 and c-MET.
    Wu Y; Yu M; Sun Z; Hou W; Wang Y; Yuan Q; Mo W
    Protein Pept Lett; 2018 Feb; 24(12):1105-1112. PubMed ID: 29046141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A detergent-based procedure for the preparation of IgG-like bispecific antibodies in high yield.
    Gupta J; Hoque M; Zaman M; Khan RH; Saleemuddin M
    Sci Rep; 2016 Dec; 6():39198. PubMed ID: 27982091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A modular IgG-scFv bispecific antibody topology.
    Orcutt KD; Ackerman ME; Cieslewicz M; Quiroz E; Slusarczyk AL; Frangioni JV; Wittrup KD
    Protein Eng Des Sel; 2010 Apr; 23(4):221-8. PubMed ID: 20019028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture.
    Wang C; Vemulapalli B; Cao M; Gadre D; Wang J; Hunter A; Wang X; Liu D
    MAbs; 2018; 10(8):1226-1235. PubMed ID: 30153083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanocell targeting using engineered bispecific antibodies.
    Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
    MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving target cell specificity using a novel monovalent bispecific IgG design.
    Mazor Y; Oganesyan V; Yang C; Hansen A; Wang J; Liu H; Sachsenmeier K; Carlson M; Gadre DV; Borrok MJ; Yu XQ; Dall'Acqua W; Wu H; Chowdhury PS
    MAbs; 2015; 7(2):377-89. PubMed ID: 25621507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies.
    Wu X; Sereno AJ; Huang F; Zhang K; Batt M; Fitchett JR; He D; Rick HL; Conner EM; Demarest SJ
    MAbs; 2015; 7(2):364-76. PubMed ID: 25611120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.
    Tustian AD; Endicott C; Adams B; Mattila J; Bak H
    MAbs; 2016; 8(4):828-38. PubMed ID: 26963837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficient bispecific monoclonal antibody purification using gradient thiophilic affinity chromatography.
    Kreutz FT; Wishart DS; Suresh MR
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):161-70. PubMed ID: 9766856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of the bispecific antibody IgG subclass on T cell redirection.
    Kapelski S; Cleiren E; Attar RM; Philippar U; Häsler J; Chiu ML
    MAbs; 2019; 11(6):1012-1024. PubMed ID: 31242061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Viscosities and Protein Interactions of Bispecific Antibodies and Their Monospecific Mixtures.
    Woldeyes MA; Josephson LL; Leiske DL; Galush WJ; Roberts CJ; Furst EM
    Mol Pharm; 2018 Oct; 15(10):4745-4755. PubMed ID: 30157651
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.
    Kim HS; Dunshee DR; Yee A; Tong RK; Kim I; Farahi F; Hongo JA; Ernst JA; Sonoda J; Spiess C
    Protein Eng Des Sel; 2017 Sep; 30(9):627-637. PubMed ID: 28985411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An Integrated Approach to Aggregate Control for Therapeutic Bispecific Antibodies Using an Improved Three Column Mab Platform-Like Purification Process.
    Andrade C; Arnold L; Motabar D; Aspelund M; Tang A; Hunter A; Chung WK
    Biotechnol Prog; 2019 Jan; 35(1):e2720. PubMed ID: 30298991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system.
    Han L; Chen J; Ding K; Zong H; Xie Y; Jiang H; Zhang B; Lu H; Yin W; Gilly J; Zhu J
    Sci Rep; 2017 Aug; 7(1):8360. PubMed ID: 28827777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species.
    Stutz C; Blein S
    J Biol Chem; 2020 Jul; 295(28):9392-9408. PubMed ID: 32404368
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing four subdomain-specific affinity resins' capability to separate half-antibody from intact bispecific antibody.
    Chen W; Zhang T; Wan Y; Li Y
    Protein Expr Purif; 2022 Oct; 198():106124. PubMed ID: 35661701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats.
    Madsen AV; Kristensen P; Buell AK; Goletz S
    MAbs; 2023; 15(1):2189432. PubMed ID: 36939220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.
    Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I
    MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.
    Shen J; Vil MD; Jimenez X; Zhang H; Iacolina M; Mangalampalli V; Balderes P; Ludwig DL; Zhu Z
    J Immunol Methods; 2007 Jan; 318(1-2):65-74. PubMed ID: 17126853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies.
    Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M
    MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.